Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001104659-22-079664
Filing Date
2022-07-14
Accepted
2022-07-14 06:02:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-C tm2220905d4_sctoc.htm SC TO-C 17532
2 EXHIBIT 99.1 tm2220905d4_ex99-1.htm EX-99.1 54335
  Complete submission text file 0001104659-22-079664.txt   73506
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filed by) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-88552 | Film No.: 221082161
SIC: 2834 Pharmaceutical Preparations